Literature DB >> 4016285

Family history and bilateral primary breast cancer.

M A Chaudary, R R Millis, R D Bulbrook, J L Hayward.   

Abstract

The prevalence of a family history of breast cancer was established in 54 women with bilateral primary breast cancer and 208 women with unilateral disease. Women with bilateral disease had significantly greater prevalence of family history than women with unilateral breast cancer (P less than 0.01). Compared with the unilateral cancers, a significantly greater proportion of bilateral cancers had first degree affected relatives (P less than 0.05). Moreover the affected relatives of probands with bilateral disease showed a significantly higher prevalence of bilateral breast cancer compared with the relatives of women with unilateral disease (P = 0.04). The findings suggested that bilateral disease was a characteristic of familial breast cancer.

Entities:  

Mesh:

Year:  1985        PMID: 4016285     DOI: 10.1007/bf01805995

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  14 in total

1.  Bilateral mammary carcinoma.

Authors:  J B HERRMANN
Journal:  Acta Unio Int Contra Cancrum       Date:  1955

2.  Nonsimultaneous bilateral carcinoma of the breast.

Authors:  T B HUBBARD
Journal:  Surgery       Date:  1953-10       Impact factor: 3.982

3.  Non-simultaneous bilateral breast carcinoma.

Authors:  S Watanatittan; M D Ram
Journal:  Surgery       Date:  1974-05       Impact factor: 3.982

4.  An epidemiologic study of breast cancer.

Authors:  B E Henderson; D Powell; I Rosario; C Keys; R Hanisch; M Young; J Casagrande; V Gerkins; M C Pike
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

5.  Bilateral breast cancer, clinical and pathological review.

Authors:  G G Finney; G G Finney; A C Montague; G L Stonesifer; C C Brown
Journal:  Ann Surg       Date:  1972-05       Impact factor: 12.969

6.  Some characteristics of familial breast cancer.

Authors:  D E Anderson
Journal:  Cancer       Date:  1971-12       Impact factor: 6.860

7.  Bilateral breast cancer and familial aggregations.

Authors:  G Sakamoto; H Sugano; F Kasumi
Journal:  Prev Med       Date:  1978-06       Impact factor: 4.018

8.  Familial breast cancer: risk to the contralateral breast.

Authors:  R E Harris; H T Lynch; H A Guirgis
Journal:  J Natl Cancer Inst       Date:  1978-05       Impact factor: 13.506

9.  Characteristics of familial breast cancer in Sweden: absence of relation to age and unilateral versus bilateral disease.

Authors:  H O Adami; J Hansen; B Jung; A Rimsten
Journal:  Cancer       Date:  1981-10-01       Impact factor: 6.860

10.  Bilateral carcinoma of the breast.

Authors:  J G Buls; R C Bennett; D P Chan
Journal:  Aust N Z J Surg       Date:  1976-11
View more
  6 in total

Review 1.  Risk assessment and management of high risk familial breast cancer.

Authors:  D G R Evans; F Lalloo
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

2.  Absence of p53 germ-line mutations in bilateral breast cancer patients.

Authors:  R Lidereau; T Soussi
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

Review 3.  Routine contralateral breast biopsy: helpful or irrelevant? Experience in 871 patients, 1979-1993.

Authors:  H S Cody
Journal:  Ann Surg       Date:  1997-04       Impact factor: 12.969

4.  Primary synchronous bilateral breast cancer: epidemiological approach.

Authors:  J Kelmendi de Ustarán; R P Meiss
Journal:  Breast Cancer Res Treat       Date:  1988-12       Impact factor: 4.872

5.  A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States)

Authors:  L S Cook; E White; S M Schwartz; B McKnight; J R Daling; N S Weiss
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

6.  Bilateral breast cancer in China: A 10-year single-center retrospective study (2006-2016).

Authors:  Hanfang Jiang; Ruyan Zhang; Xiaoran Liu; Ran Ran; Jiayang Zhang; Yaxin Liu; Xinyu Gui; Yifei Chen; Kun Li; Bin Shao; Ying Yan; Xu Liang; Guohong Song; Lijun Di; Huiping Li
Journal:  Cancer Med       Date:  2021-08-04       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.